embecta's profile picture. News & info about embecta (formerly part of BD) a global #medtech company singularly focused on #DiabetesCare. BD is the manufacturer of advertised products.

embecta

@embecta

News & info about embecta (formerly part of BD) a global #medtech company singularly focused on #DiabetesCare. BD is the manufacturer of advertised products.

Today we hosted our Third Quarter Fiscal Year 2025 earnings call. You can read the results in our press release here: bit.ly/4m856s3

embecta's tweet image. Today we hosted our Third Quarter Fiscal Year 2025 earnings call. You can read the results in our press release here: bit.ly/4m856s3

Join our third quarter fiscal year 2025 earnings call Friday at 8:00AM ET. Tune in here: investors.embecta.com.

embecta's tweet image. Join our third quarter fiscal year 2025 earnings call Friday at 8:00AM ET. Tune in here: investors.embecta.com.

We’re excited to host our inaugural Analyst and Investor Day on Thursday, May 22, to showcase our strategic vision and long-range financial plan. Register at investorday.embecta.com.

embecta's tweet image. We’re excited to host our inaugural Analyst and Investor Day on Thursday, May 22, to showcase our strategic vision and long-range financial plan. Register at investorday.embecta.com.

Today we hosted our Second Quarter Fiscal Year 2025 earnings call. You can read the results in our press release here: bit.ly/4jQ0AgC

embecta's tweet image. Today we hosted our Second Quarter Fiscal Year 2025 earnings call. You can read the results in our press release here: bit.ly/4jQ0AgC

Join our Second Quarter Fiscal Year 2025 earnings call tomorrow at 8:00AM ET. Tune in here: investors.embecta.com.

embecta's tweet image. Join our Second Quarter Fiscal Year 2025 earnings call tomorrow at 8:00AM ET. Tune in here: investors.embecta.com.

Find your purpose supporting the #diabetes community by driving innovation in the field. Learn more about our open careers here: bit.ly/49AuOzu

embecta's tweet image. Find your purpose supporting the #diabetes community by driving innovation in the field. Learn more about our open careers here: bit.ly/49AuOzu

Are your patients with #diabetes staying vigilant about #kidneycare? These #WorldKidneyDay reminders can help them keep their kidney health top of mind.


Today we hosted our First Quarter Fiscal Year 2025 earnings call. You can read the results in our press release here: bit.ly/3CIijGl

embecta's tweet image. Today we hosted our First Quarter Fiscal Year 2025 earnings call. You can read the results in our press release here: bit.ly/3CIijGl

Join our First Quarter Fiscal Year 2025 earnings call tomorrow at 8:00AM ET. Tune in here: investors.embecta.com.

embecta's tweet image. Join our First Quarter Fiscal Year 2025 earnings call tomorrow at 8:00AM ET. Tune in here: investors.embecta.com.

Earlier today, our President and CEO Dev Kurdikar presented at #JPM2025. Miss the live presentation? Check out his remarks here: bit.ly/4fWJOJJ

embecta's tweet image. Earlier today, our President and CEO Dev Kurdikar presented at #JPM2025. 

Miss the live presentation? Check out his remarks here: bit.ly/4fWJOJJ

Come say hello to us tomorrow at #JPM2025! Our President and CEO Dev Kurdikar will be presenting at 7:30 a.m. PT / 10:30 a.m. ET. Not attending? Listen to the webcast here: bit.ly/4fWJOJJ

embecta's tweet image. Come say hello to us tomorrow at #JPM2025! Our President and CEO Dev Kurdikar will be presenting at 7:30 a.m. PT / 10:30 a.m. ET.

Not attending? Listen to the webcast here: bit.ly/4fWJOJJ

Happy New Year 2025!

embecta's tweet image. Happy New Year 2025!

We're looking forward to presenting at the 43rd annual J.P. Morgan Healthcare Conference. Read more about our participation at #JPM2025 in our release: investors.embecta.com/news-releases/…


embecta reposted

We’re proud to partner with @embecta. Our deep expertise in the life sciences & healthcare sectors alongside our capabilities in data and technologies enables embecta’s vision to make a meaningful impact in the healthcare sector. bit.ly/4fsSLf5


embecta reposted

Lunch is absorbing and insulin is flowing as #DiabetesMine founder Amy Tenderich gives the opening presentation to kick off #DData2024 Many thanks to the sponsors: @dexcom @EliLillyandCo @myomnipod @embecta and @MannKindCorp


Join our second quarter fiscal year 2024 earnings call tomorrow at 8:00AM ET. Tune in here: investors.embecta.com.

embecta's tweet image. Join our second quarter fiscal year 2024 earnings call tomorrow at 8:00AM ET. Tune in here: investors.embecta.com.

Today is the day! We're excited to start #ATTD2024 with our Industry Symposium. Join us for insights into exciting #diabetes technology research. Elevate your diabetes care knowledge with us today!

embecta's tweet image. Today is the day! We're excited to start #ATTD2024 with our Industry Symposium. Join us for insights into exciting #diabetes technology research. Elevate your diabetes care knowledge with us today!

Tomorrow, these distinguished faculty will present new research on the potential of #insulin pump therapy for #T2D and the future of personalized #diabetes care at our #ATTD2024 Industry Symposium. Hope to see you there!

embecta's tweet image. Tomorrow, these distinguished faculty will present new research on the potential of #insulin pump therapy for #T2D and the future of personalized #diabetes care at our #ATTD2024 Industry Symposium. Hope to see you there!

We are looking forward to coming together with other #diabetes technology industry leaders at #ATTD2024 in Florence, Italy.

embecta's tweet image. We are looking forward to coming together with other #diabetes technology industry leaders at #ATTD2024 in Florence, Italy.

Kick off #ATTD2024 on March 6th at our Industry Symposium on the role of insulin pump therapy in #diabetes treatment.

embecta's tweet image. Kick off #ATTD2024 on March 6th at our Industry Symposium on the role of insulin pump therapy in #diabetes treatment.

Loading...

Something went wrong.


Something went wrong.